In a significant reinforcement of international health diplomacy, Belgium and the World Health Organization (WHO) have concluded a intensive three-day strategic dialogue, marking a new chapter in their longstanding partnership. The meetings, held in early March 2025, served as a high-level forum to synchronize Belgium’s development cooperation priorities with the WHO’s evolving 14th General Programme of Work (GPW14).
The dialogue underscored a shared commitment to building resilient health systems, achieving universal health coverage (UHC), and ensuring equitable access to medical countermeasures. By aligning the administrative and political expertise of the Belgian Federal government with the Flemish and Walloon regional authorities, the partnership seeks to create a cohesive, multi-layered approach to addressing the most pressing health challenges of the 21st century.
The Pillars of the Strategic Dialogue
The core of the discussions centered on three primary objectives: the acceleration of equitable access to health technologies, the strengthening of global pandemic preparedness, and the advancement of Universal Health Coverage.
1. Equitable Access to Essential Medicines
A focal point of the dialogue was the progress made under the Belgian-funded Access to Medicines programme. As global supply chains remain fragile, the partnership highlighted the necessity of local production capabilities. By analyzing country-level implementation in Senegal, both parties identified market-shaping strategies as the critical lever for long-term sustainability. The discourse moved beyond mere funding, focusing on how to build robust, self-sustaining pharmaceutical ecosystems in partner nations that can withstand external shocks.
2. Pandemic Prevention and One Health
The dialogue addressed the volatile nature of global health emergencies. With negotiations regarding the international pandemic agreement still a matter of high urgency, Belgium and the WHO assessed the current global architecture for health security. A key emphasis was placed on the "One Health" approach—recognizing the interconnectedness of human, animal, and environmental health. The discussion delved into the mitigation of biological risks and the increasing threat of zoonotic diseases, with the WHO providing a stark reality check through an analysis of its emergency response operations in Gaza.
3. Universal Health Coverage (UHC)
The UHC-Partnership, which has been a cornerstone of the Belgian-WHO relationship since 2021, served as the blueprint for future collaboration. Participants reviewed the impact of these initiatives in partner countries, specifically highlighting the Democratic Republic of Congo. The dialogue explored how to better align WHO country office programmes with Belgium’s bilateral development aid, ensuring that resources are not fragmented but channeled toward tangible, measurable outcomes in primary health care and mental health services.
Chronology of the Strategic Engagement
The strategic dialogue was structured as a methodical progression from retrospective review to future-oriented planning:
- Day One: The Global Landscape and Strategic Alignment: The opening sessions were led by H.E. Christophe Payot, Ambassador of Belgium to the United Nations in Geneva. Discussions focused on the "evolving global health landscape," particularly in the wake of Belgium’s presidency of the Council of the European Union in 2024. This established the political context for the ensuing technical discussions.
- Day Two: Technical Deep-Dives: The second day transitioned into granular reviews of specialized programmes. Experts from WHO Headquarters, the Regional Office for Africa, and the Regional Office for Europe provided detailed briefings on Neglected Tropical Diseases (NTDs) and Sexual, Reproductive Health and Rights (SRHR). The focus was on evidence-based methodologies and the importance of rigorous data collection in informing public health policy.
- Day Three: Synthesis and Future Frameworks: The final day was dedicated to the formalization of the next phase of the partnership. The discussions centered on the "WHO-Belgium Country Cooperation Strategy," a framework designed to ensure that the collaboration remains agile and responsive to the needs of the 14th General Programme of Work (GPW14).
Supporting Data and Evidence-Based Impact
The partnership between Belgium and the WHO is underpinned by a commitment to data-driven development. Throughout the dialogue, several key performance indicators were examined to justify the continuation and expansion of funding:
- Regional Efficacy: The success stories from Mozambique and Senegal were frequently cited as evidence that Belgian investments in local health infrastructure produce high-yield outcomes. In these contexts, the WHO’s role as an intermediary—providing technical expertise to support the implementation of Belgian funds—has proven effective in bypassing bureaucratic hurdles.
- The UHC-Partnership Metric: From 2021 to 2024, the collaboration focused on institutionalizing health coverage. Data presented during the dialogue indicated that in target countries, the integration of mental health services into primary care models had improved significantly, providing a scalable model for other regions.
- Market Shaping and Local Production: The WHO presented evidence regarding the economic impact of localizing pharmaceutical production. By fostering regional hubs for vaccine and medicine manufacturing, the partnership aims to reduce dependence on external imports, which proved to be a critical failure point during the COVID-19 pandemic.
Official Responses and Diplomatic Sentiment
The atmosphere of the meetings was marked by a sense of mutual respect and a shared recognition of the gravity of current global challenges.
Mr. Koen Van Acoleyen, Minister Counselor at the Permanent Representation of Belgium to the UN, captured the sentiment of the Belgian delegation: "After listening to the leaders and experts of WHO, we now better understand how they are navigating these challenging times. We are honoured that we can walk this road together."
Dr. Catharina Boehme, Assistant Director-General for External Relations and Governing Bodies at the WHO, emphasized the value of the diverse Belgian participation: "We thank you for your support, honesty, and strong engagement for global health. Your efforts in supporting our work in Mozambique and Senegal are clear examples of the crucial work we accomplish together."
Mr. Dirk Brems, Director of Thematic and Multilateral Cooperation, reflected on the future of the alliance: "We recognize WHO as a trustworthy partner in global health. We felt proud hearing how crucial our support is to the Organization and how it is having a positive impact at country, regional, and global levels. It’s important we continue these discussions as we tread uncharted territories."
Implications for the Global Health Agenda
The successful conclusion of this dialogue holds significant implications for the international community.
1. Strengthening Multilateralism
In an era characterized by geopolitical fragmentation, the reinforced Belgium-WHO partnership serves as a testament to the continued relevance of multilateral institutions. By aligning regional government interests (Flemish and Walloon) with federal policy, Belgium is setting a standard for how member states can act as force multipliers for global health organizations.
2. The GPW14 Framework
The WHO’s 14th General Programme of Work (GPW14) aims to reposition health at the center of development. The consensus reached during the dialogue—that UHC and health systems strengthening are the primary pillars of this agenda—ensures that the WHO will have a clear mandate in its upcoming prioritization cycles. Belgium’s commitment to this vision provides the necessary political and financial momentum to move from conceptual framework to operational reality.
3. Addressing Future Shocks
The explicit focus on zoonoses and biological risks indicates a shift toward a more proactive, rather than reactive, stance on health security. By integrating risk mitigation strategies into the core of their bilateral agreement, Belgium and the WHO are better positioning themselves to detect and neutralize health threats before they escalate into pandemics.
Conclusion
As the world enters a period of heightened biological and systemic risk, the synergy between Belgium and the World Health Organization offers a model of stable, evidence-based cooperation. The "uncharted territories" mentioned by Mr. Brems refer to a world where climate change, geopolitical instability, and emerging pathogens are constant variables. By renewing their Country Cooperation Strategy and doubling down on the principles of equity and universal access, both parties have demonstrated that international solidarity is not only a moral imperative but a pragmatic necessity for global survival.
About the Author
